CompanyPositionCountry
ABIONICCEO and founderSwiss
Session
How to increase the number of MedTech unicorns in Europe?

Nicolas Durand is Founder and Chief Executive Officer at Abionic SA, a Swiss company and
spin-off from European leading technology school EPFL (Swiss Federal Institute of Technology
Lausanne, Switzerland). Abionic has developed world’s fastest diagnostic platform, the
abioSCOPE, a CE-marked versatile in-vitro solution that provides hospitals and health
practitioners with instant quantitative diagnosis for various types of applications such as
sepsis, allergy and iron deficiency.
Since April 2018, Nicolas is a member of the Strategic Board of the Vaud Chamber of
Commerce and Industry (CVCI), and is an Intelligence Officer at the Swiss Army, working
directly with three-stars General Daniel Baumgartner for promoting military management skills
in the industry.
Nicolas holds a Master of Science in micro-engineering from EPFL with a specialization in
production techniques. He was involved in the development of resonating biosensors at
Carnegie Mellon University (USA), and is the winner of the 2006 Omega Award (Best Master
thesis in micro-engineering). He is the founder of EPFL aeronautics association, and was the
president of EPFL robotic association between 2002 and 2005.
Between 2006 and 2010, Nicolas’s PhD research on biomolecular diffusion in nanofluidics led
to several scientific publications and patents, which is the core of Abionic’s technology.
With Abionic, Nicolas is the recipient of more than 20 entrepreneurial awards including the
Young Entrepreneur Award. Notably, Nicolas was elected Captain of the Swiss Venture Leaders
in 2010 who represented Swiss innovation in the USA.
On the private side, Nicolas owns a pilot license with aerobatic, was astronaut candidate for
the European Space Agency in 2006 and participated to the 8th Student Parabolic Flight
Campaign as group leader.